Lyfebulb – Veloxis Innovation Challenge: Transforming Organ Transplantation

APPLY
Cary, North Carolina
October 13 - 14, 2022

CHALLENGE TIMELINE

July 26, 2022
Applications Open
August 21, 2022
Submission Deadline
September 6, 2022
Finalist Announcement
Oct 13-14, 2022
Innovation Challenge
October 14, 2022
Winner Announcement

ABOUT THE SUMMIT AND AWARD

The Lyfebulb-Veloxis Innovation Challenge will take place in October 2022 at Veloxis’ headquarters and is currently accepting applications through August 21, 2022. Selected applicants (i.e., finalists) will receive an invitation to pitch their ideas and business solutions live to an expert panel of judges comprised of healthcare industry, medical, and patient leaders over the course of a two-day summit.

Prizes will be awarded to two finalists to further grow their companies. The Innovation Award will be presented to a for-profit company and includes $25,000 monetary grant. The Impact Award will be presented to a not-for-profit company and includes $15,000 monetary grant. Competing finalists may be considered by Veloxis for possible partnerships or investment opportunities.

In addition to the pitch competition, finalists will have the opportunity to engage with representatives from the patient community, industry, Lyfebulb, and Veloxis through workshops and learning hubs.

KEY PILLARS OF INNOVATION

Through Lyfebulb and Veloxis Pharmaceutical’s shared commitment to patients and their loved ones, the Lyfebulb-Veloxis Innovation Challenge is seeking a wide range of solutions to improve lived-experience and outcomes for all those affected by transplant:

    • New treatments, methods and/or procedures
    • Diagnostics and patient monitoring
    • System-wide improvements to care
    • Advancements in health equity
    • Quality of life
    • Patient services

Solutions may any stage of the patient journey from pre-transplant to post-transplant longer-term management. Examples include, but are not limited to: organ supply, rejection, transplant procedures, comorbidities / side effects, patient education, and dialysis.

SHARE

CRITERIA FOR APPLYING TO THE CHALLENGE

Applications are open globally; USA and international companies are encouraged to apply.

CATEGORIES

    • Drugs / therapeutics
    • Devices / technology
    • Products
    • Services

ORGANIZATIONS

    • For-profits
    • Not-for-profits
    • Individuals with registered companies

STAGES OF DEVELOPMENT

    • Idea stage
    • Early development
    • Mature development

JUDGING CRITERIA

The judging panel will assess the following:

UNMET NEED

Strategic basis for addressing unmet needs facing patients, care partners, and/or professionals

Demonstrated ability of the innovation to address

these challenges

IMPACT

Potential of the innovation to improve outcomes or lived-experience of people affected by transplant

Degree of market impact and patient impact

Measurability of impact

MARKET FEASIBILITY

Uniqueness to the market

Feasibility of development and implementation

Market sustainability

THE CHALLENGE IN NUMBERS

21

August

Applications close on Wednesday, August 21, 2022, at 11:59 PM EDT

2

Days

The Challenge will take place
October 13 – 14, 2022

$25

Thousand

One entrepreneur will be awarded the Innovation Award, including $25,000

$15

Thousand

One entrepreneur will be awarded the Impact Award, including $15,000

DRIVING CHANGE

The 2022 Innovation Challenge is one component of a larger partnership between Lyfebulb and Veloxis Pharmaceuticals, which is built upon a shared commitment to advancing patient-driven innovation in transplantation to attain improved outcomes for patients as well as care partners. The Lyfebulb Innovation Challenge, sponsored by Veloxis Pharmaceuticals, stems from the concept of the Lyfebulb Entrepreneur Circle established in 2015, which features individuals who have created a product and/or a company in response to their personal experiences with a chronic illness (through their own diagnosis or that of a loved one).

Additionally, Veloxis Pharmaceuticals is sponsoring a transplant education series in partnership with Lyfebulb and Columbia University. Information and recordings of webinars from this series can be found on TransplantLyfe, Lyfebulb’s digital platform for transplant patients and care partners, at www.transplantlyfe.com/webinars.